Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

Patients amenable to interventional procedure for lowering blood pressure

The analysis, presented at TCT 2021, included input from 400 patients with high blood pressure.

CABG still the ‘treatment of choice’ for patients with complex three-vessel CAD

The findings were presented at TCT 2021 and published in the New England Journal of Medicine.

Vascular surgeons playing a key role as consultants in today’s trauma centers

One facility saw vascular surgeon consultations increase by more than 500% over the course of 15 years.

Using pulmonary artery pressure monitoring to manage obese HF patients leads to strong outcomes

Researchers examined data from the CardioMEMS Post Approval Study, sharing their findings in JACC: Heart Failure.

FDA panel meets to review safety of endovascular graft device

While the manufacturer says its solution is a safe and effective treatment option, the FDA wanted more information.

Stimulants increase the short-term risk of heart attack, stroke, arrhythmia in older patients

Researchers emphasized that safety considerations should be included when stimulants are prescribed to older adults.

IVUS-guided PCI boosts outcomes for AMI patients

A new study in JACC: Cardiovascular Interventions highlights multiple long-term benefits of IVUS-guided PCI compared to angiography-guided PCI.

CAC scores not always reliable for ruling out obstructive CAD

Researchers tracked data from more than 23,000 patients, encountering an 'apparent paradox' along the way.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall